drugset / Trial / NCT01015235

Safety and Efficacy Study of KAI-1678 to Treat Subjects With Postoperative Pain

NCT01015235

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether KAI-1678 is effective in the treatment of postoperative pain following total hip or total knee replacement.

Timeline

Start
2008-12
Primary completion
2010-02
Completion
2010-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator KAI-1678 Unknown Subcutaneous
Comparator Ketorolac Tromethamine Small molecule Intravenous

Indications

No indication recorded.